title: Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
authors.affiliation: Department of Neurology, University of Würzburg, , Würzburg, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Zeller
authors.forename: K
authors.initials: K
authors.lastname: Reiners
authors.forename: S
authors.initials: S
authors.lastname: Bräuninger
authors.forename: M
authors.initials: M
authors.lastname: Buttmann
mesh_terms: D015761:4-Aminopyridine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D019054:Evoked Potentials, Motor; D005260:Female; D006801:Humans; D007866:Leg / Q000294:innervation; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology*; D009431:Neural Conduction / Q000187:drug effects; D026902:Potassium Channel Blockers / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011237:Predictive Value of Tests; D011446:Prospective Studies; D016138:Walking
chemical_list: D026902:Potassium Channel Blockers; D015761:4-Aminopyridine
keywords: Clinical Neurology; Gait; MAgnetic Stimulation; Multiple Sclerosis; Neurophysiology, Motor